Pfizer seeks FDA approval of COVID-19 boosters for children ages 5 to 11
Pfizer Inc. announced Tuesday that it has asked the U.S. Food and Drug Administration to approve emergency use of its booster shot for children ages 5 to 11 years.The application hinges on a study of
Updated on: February 29,2024
15
Pfizer seeks FDA approval of COVID-19 boosters for children ages 5 to 11
Pfizer Inc. announced Tuesday that it has asked the U.S. Food and Drug Administration to approve emergency use of its booster shot for children ages 5 to 11 years.The application hinges on a study of
Updated on:February 29,2024
15
